Annotation. Today, diseases of the cardiovascular system retain their leading position among incidence in world. The presence comorbid pathology form type 2 diabetes mellitus (DM) significantly complicates course these diseases, worsening its prognosis. aim study: to analyze prognostic value asymmetric dimethylarginine (ADMA) as a marker recurrent events patients with acute myocardial infarctio...

There is a growing clinical evidence to support the hypothesis that asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase is a new independent cardiovascular risk factor. ADMA mediates endothelial dysfunction in lipid disorders, coronary artery disease, chronic heart failure, diabetes mellitus and hypertension. The aim of this review was to summarize the latest ev...